低血糖指数面条和意大利面:谷物类型,成分和加工方法
Congli Cui1, Yong Wang2, Jian Ying3
1College of Engineering, Beijing Advanced Innovation Center for Food Nutrition and Human Health, National Energy R & D Center for Non-food Biomass, China Agricultural University, P. O. Box 50, 17 Qinghua Donglu, Beijing 100083, China.
Food chemistry
|August 21, 2023
概括
通过纤维和多等成分开发低血糖指数 (GI) 面条可以帮助控制血糖水平. 这项研究探讨了减少面条GI的方法,以改善健康结果.
科学领域:
- 食品科学 食品科学 食品科学
- 营养科学 营养科学
- 饮食研究 饮食研究
背景情况:
- 高血糖指数 (GI) 的面条会对血糖控制产生负面影响.
- 饮食修改对于控制异常血糖水平至关重要.
- 越来越需要更健康的面条替代品.
研究的目的:
- 审查最近在开发低GI面条方面的进展.
- 为了探索低GI面条的潜在健康益处.
- 了解影响面条胃肠道和血糖反应的因素.
主要方法:
- 加入可溶性食纤维,改性粉,蛋白质和植物多.
- 分析加工,储存和技术对面条GI的影响.
- 通过阻碍酶-粉相互作用来研究GI减肥的机制.
主要成果:
- 可溶性食纤维,蛋白质和植物聚醇有效地减少了面条的GI.
- 加工和方法显著影响面条的葡萄糖反应.
- 特定的成分和技术在降低面条的GI方面表现有前途.
结论:
- 低GI面条提供了一个有前途的血糖管理策略.
- 对原料和加工的进一步研究对于功能性食品的开发至关重要.
- 优化面条配方可以提高营养成分和健康益处.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
355
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
205
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
205
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Carbohydrates: Dietary Sources and Requirements
546
Carbohydrates are predominantly obtained from plant sources. With the exception of lactose found in milk and insignificant glycogen amounts in meat, most consumed carbohydrates have plant origins. Monosaccharides and disaccharides, or sugars, can be sourced from fruits, honey, milk, sugar cane, and sugar beets. Grains and vegetables are rich in the polysaccharide starch. Two types of polysaccharides provide fiber: cellulose, which is abundant in many vegetables, forms undigestible roughage or...
546
Oral Hypoglycemic Agents: Glinides
184
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
184
Hypoglycemia and Glucagon
296
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
296


